Inventor · disambiguated record
Norton P. Peet
Also filed as: PEET NORTON · PEET NORTON P
88 granted patents·6 pending applications·792 citations·filing 1975–2022
99Inventor score
Files withMERRELL DOW PHARMA29MERRELL PHARMA INC15DOW CHEMICAL CO12BIOMARIN PHARM INC9AVENTIS PHARMA INC8
Top patents by PatentIndex Score
94 records- 0194US8957066B2Histone deacetylase inhibitorsREPLIGEN CORP·Filed 2013·Granted Feb 17, 2015·20 cites·13 claims
- 0293US9512143B2Histone deacetylase inhibitorsBIOMARIN PHARM INC·Filed 2015·Granted Dec 6, 2016·11 cites·18 claims
- 0389US9908899B2Histone deacetylase inhibitorsBIOMARIN PHARM INC·Filed 2016·Granted Mar 6, 2018·5 cites·24 claims
- 0489US6413974B16,9,-disubstituted 2-[trans-(4-aminocyclohexyl) amino] purinesAVENTIS PHARMA INC·Filed 1999·Granted Jul 2, 2002·94 cites·27 claims
- 0587US6693072B2Elastase inhibitorsAVENTIS PHARMA INC·Filed 2000·Granted Feb 17, 2004·21 cites·11 claims
- 0686US9796664B2Compositions including 6-aminohexanoic acid derivatives as HDAC inhibitorsBIOMARIN PHARM INC·Filed 2016·Granted Oct 24, 2017·5 cites·19 claims
- 0786US9540395B2Histone deacetylase inhibitorsJACQUES VINCENT·Filed 2012·Granted Jan 10, 2017·9 cites·26 claims
- 0886US6479487B16, 9-disubstituted 2-[trans-(4-aminocyclohexyl)amino] purinesAVENTIS PHARMA INC·Filed 1999·Granted Nov 12, 2002·78 cites·193 claims
- 0981US9265734B2Compositions including 6-aminohexanoic acid derivatives as HDAC inhibitorsRUSCHE JAMES R·Filed 2009·Granted Feb 23, 2016·8 cites·39 claims
- 1081US5051534ANovel cyclopropyl squalene derivatives and their use as inhibitors of cholesterol synthesisMERRELL DOW PHARMA·Filed 1990·Granted Sep 24, 1991·18 cites·5 claims
- 1180US5256650ASelective adenosine receptor agentsMERRELL DOW PHARMA·Filed 1992·Granted Oct 26, 1993·17 cites·11 claims
- 1280US5208240A8-substituted purines as selective adenosine receptor agentsMERRELL DOW PHARMA·Filed 1991·Granted May 4, 1993·39 cites·13 claims
- 1379US5359131ASulfonic acid derivatives in the treatment of viral diseasesMERRELL DOW PHARMA·Filed 1993·Granted Oct 25, 1994·16 cites·11 claims
- 1476US5691368ASubstituted oxazolidine calpain and/or cathepsin B inhibitorsHOECHST MARION ROUSSEL INC·Filed 1995·Granted Nov 25, 1997·41 cites·16 claims
- 1575US10059723B2Histone deacetylase inhibitorsBIOMARIN PHARM INC·Filed 2016·Granted Aug 28, 2018·1 cites·26 claims
- 1673US8273744B2AMPK modulatorsBIRNBERG NEAL C·Filed 2009·Granted Sep 25, 2012·3 cites·12 claims
- 1773US5102915ACyclopropyl squalene derivatives and their use as inhibitors of cholesterol synthesisMERRELL DOW PHARMA·Filed 1991·Granted Apr 7, 1992·12 cites·1 claims
- 1873US4328244ANovel (((substituted-phenyl)methyl)amino)benzenesulfonic acids and pharmaceutically-acceptable salts thereofDOW CHEMICAL CO·Filed 1980·Granted May 4, 1982·11 cites·18 claims
- 1973US4064348A2-Cycloalkyl-amino-2-oxazolinesDOW CHEMICAL CO·Filed 1976·Granted Dec 20, 1977·7 cites·12 claims
- 2072US9212134B2Inhibitors of viral entry into mammalian cellsBASU ARNAB·Filed 2011·Granted Dec 15, 2015·3 cites·11 claims
- 2172US5728874AAnti-HIV achiral polyurea oligomers, a process for creating them, formulations using them, and their use in the treatment of AIDSMERRELL PHARMA INC·Filed 1993·Granted Mar 17, 1998·14 cites·50 claims
- 2272US2020148704A1Histone deacetylase inhibitorsBIOMARIN PHARM INC·Filed 2019·Application pending·0 cites
- 2371US5510333AInhibitors of Cathepsin G and elastase for preventing connective tissue degradationMERRELL PHARMA INC·Filed 1995·Granted Apr 23, 1996·29 cites·10 claims
- 2471US5382709AAlpha-mannosidase and fucosidase inhibitorsMERRELL DOW PHARMA·Filed 1993·Granted Jan 17, 1995·9 cites·4 claims
- 2570US5977074AInhibitors of β-amyloid protein productionMERRELL PHARMA INC·Filed 1994·Granted Nov 2, 1999·11 cites·16 claims
- 2669US10301323B2Histone deacetylase inhibitorsBIOMARIN PHARM INC·Filed 2018·Granted May 28, 2019·0 cites·14 claims
- 2769US6008196APerfluoroalkyl ketone inhibitors of elastase and processes for making the sameHOECHST MARION ROUSSEL INC·Filed 1995·Granted Dec 28, 1999·28 cites·9 claims
- 2867US10280182B2Histone deacetylase inhibitorsBIOMARIN PHARM INC·Filed 2018·Granted May 7, 2019·0 cites·10 claims
- 2967US8906945B2Inhibitors of bacterial type III secretion systemMOIR DONALD T·Filed 2010·Granted Dec 9, 2014·2 cites·7 claims
- 3067US4107436ASubstituted N-(2-hydroxyethyl)morpholino carboxamidesDOW CHEMICAL CO·Filed 1977·Granted Aug 15, 1978·4 cites·5 claims
- 3165US10981933B2Histone deacetylase inhibitorsBIOMARIN PHARM INC·Filed 2019·Granted Apr 20, 2021·0 cites·16 claims
- 3265US5948886AAcylated enol derivatives of α-ketoesters and α-ketoamidesHOECHST MARION ROUSSEL INC·Filed 1997·Granted Sep 7, 1999·28 cites·12 claims
- 3365US5677293A16 unsaturated C17 heterocyclic steroids useful as steroid C17-20 lyase inhibitorsMERRELL PHARMA INC·Filed 1994·Granted Oct 14, 1997·11 cites·20 claims
- 3465US4526979ACarbamates and oxalamides of amino-N-(1H-tetrazol-5-yl)benzamidesMERRELL DOW PHARMA·Filed 1983·Granted Jul 2, 1985·9 cites·9 claims
- 3565US4419357A3-(1H-Tetrazol-5-yl)-4(3H)-quinazolinonesDOW CHEMICAL CO·Filed 1982·Granted Dec 6, 1983·9 cites·11 claims
- 3665US4254125A2-Chloro-3-phenoxypyrazines and 2-chloro-6-phenoxypyrazines possessing antiviral activityDOW CHEMICAL CO·Filed 1980·Granted Mar 3, 1981·6 cites·33 claims
- 3764US10526346B2Histone deacetylase inhibitorsBIOMARIN PHARM INC·Filed 2018·Granted Jan 7, 2020·0 cites·14 claims
- 3864US8980895B2AMPK modulatorsBIRNBERG NEAL C·Filed 2012·Granted Mar 17, 2015·1 cites·6 claims
- 3964US6861524B2Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agentsAVENTIS PHARMA INC·Filed 2001·Granted Mar 1, 2005·2 cites·10 claims
- 4061US6642231B26,9-disubstituted 2-[trans-(4-aminocyclohexyl)amino] purinesAVENTIS PHARMA INC·Filed 2002·Granted Nov 4, 2003·1 cites·21 claims
- 4160US7429595B2Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agentsAVENTIS PHARMA INC·Filed 2003·Granted Sep 30, 2008·1 cites·16 claims
- 4260US5047534ASelective adenosine receptor agentsMERRELL DOW PHARMA·Filed 1990·Granted Sep 10, 1991·19 cites·18 claims
- 4360US4277492ANovel 4-bis((Phenylmethyl)amino)-benzenesulfonic acids possessing antiviral activityDOW CHEMICAL CO·Filed 1980·Granted Jul 7, 1981·6 cites·15 claims
- 4459US5252565AHaloethyl-substituted steroid enzyme inhibitorsMERRELL DOW PHARMA·Filed 1991·Granted Oct 12, 1993·11 cites·12 claims
- 4559US5011835ASubstituted triazolopyridazines, pharmaceutical compositions and useMERRELL DOW PHARMA·Filed 1990·Granted Apr 30, 1991·14 cites·19 claims
- 4659US4526890A3,6,7,8-Substituted-s-triazolo[4,3-b]pyridazines as bronchodilatorsDOW CHEMICAL CO·Filed 1981·Granted Jul 2, 1985·4 cites·22 claims
- 4758US5240707AAlpha-mannosidase and fucosidase inhibitorsMERRELL DOW PHARMA·Filed 1991·Granted Aug 31, 1993·9 cites·1 claims
- 4858US2011098323A1Inhibitors of bacterial biofilm formationMICROBIOTIX INC·Filed 2009·Application pending·0 cites
- 4957US6069232APolyfluoroalkyl tryptophan tripeptide thrombin inhibitorsHOECHST MARION ROUSSEL INC·Filed 1996·Granted May 30, 2000·16 cites·22 claims
- 5055US5965548A.increment.16 unsaturated C17 heterocyclic steroids useful as steroid C17-20 lyase inhibitorsMERRELL PHARMA INC·Filed 1998·Granted Oct 12, 1999·8 cites·12 claims
Showing the top 50 of 94 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Norton P. Peet files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →